Farallon Capital Management LLC Bio Atla, Inc. Transaction History

Farallon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$29.44 - $43.74 $21.3 Million - $31.6 Million	-722,141 Reduced 80.05%	180,000 $0
Q2 2021 Aug 13, 2021	SELL	$38.07 - $56.17 $22.5 Million - $33.1 Million	-589,919 Reduced 39.54%	902,141 $0
Q1 2021 May 17, 2021	SELL	$32.41 - $70.91 $15.4 Million - $33.7 Million	-475,000 Reduced 24.15%	1,492,060 $75.9 Million
Q4 2020 Feb 16, 2021	BUY	$31.02 - $35.16 $61 Million - $69.2 Million	1,967,060 New	1,967,060 $0

17.3M

500

33.5K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.